drugset
drugset / Trial / NCT00591162

Bone Disease in Severely Burned Children

NCT00591162 ↗

Phase 2/3 Terminated 254 enrolled The University of Texas Medical Branch, Galveston
NaSingle-groupOpen-labelTreatment

Summary

Bone metabolism is adversely affected by severe burns in children for a period of time.

Timeline

Start
1992-10
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tetracycline Unknown 10 mg/kg Intravenous

Indications

No indication recorded.